https://european-biotechnology.net/wp-content/uploads/2024/09/LevinJM_Headshot_FINAL_20161028-1030x677-1.jpg6771030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-09-30 04:00:172024-09-30 04:00:17Long version of The BIOSECURE Act: The West’s Wake-Up Call to China’s Biotech Dominance
https://european-biotechnology.net/wp-content/uploads/2024/09/Alessio-Cantore-e1727256487625.jpg242430Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-09-25 09:33:552024-09-25 09:33:55Genespire raises US$52m in Series B round
https://european-biotechnology.net/wp-content/uploads/2024/09/Vicebio_Respiratory_Syncytial_Virus_RSV_EM_PHIL_2175_lores-e1727100671948-1030x580-1.jpg5801030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-09-23 14:12:002024-09-23 14:12:00Vicebio Ltd cashes in US$100m in Series B financing
https://european-biotechnology.net/wp-content/uploads/2024/09/324EB_von-der-Leyen_tg-1030x687-1.webp6871030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-09-18 09:20:452024-09-26 16:32:01Von der Leyen names new EU Commissioners
https://european-biotechnology.net/wp-content/uploads/2024/09/ImmunOS.png404748Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-09-17 13:17:552024-09-17 13:17:55ImmunOs Therapeutics AG raises US$11m in Series C financing
